Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Genmab
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants must be ≥ 18 years of age at the time of informed consent; have measurable disease according to RECIST 1.1; Eastern Cooperative Oncology Group (ECOG) performance status (PS) score of 0 or 1; adequate organ, bone marrow, liver, coagulation, and renal function; and be willing to provide a pretreatment tumor specimen.
All participants must have pathologically confirmed diagnosis of advanced solid tumor.
Participants must have metastatic or unresectable locally advanced, recurrent disease not amenable to further local therapy and must have previously received therapies known to confer clinical benefit (unless ineligible to receive, refused to receive, or therapy is unavailable in the region).
You may not be if
\- Prior treatment with topoisomerase 1-based antibody-drug conjugate (ADC) therapy.
